Skip to Content

MetLife Inc MET Stock Quote

| Rating as of

Morningstar‘s Stock Analysis MET

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Rising Rates Are a Positive for Life Insurers in the Long Run; Relaunching MetLife With $63 FVE

Suryansh Sharma Equity Analyst

Analyst Note

| Suryansh Sharma |

We are relaunching MetLife Inc with a fair value estimate of $63 per share after taking a fresh look at it. Our fair value estimate implies that MetLife is currently fairly valued. MetLife provides a variety of insurance and financial services products, including life, dental, disability, vision, accident & health, stable value, and annuities in various countries. We assign a no-moat rating, a stable moat trend, and a standard capital allocation rating to the company.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MET

Company Profile MET

Business Description

MetLife is one of the largest life insurers in the U.S. by assets and provides a variety of insurance and financial services products. The company is organized into five segments: U.S., Asia, Latin America, EMEA, and MetLife Holdings. The U.S. business contributes around 41% of earnings and is broken into the group benefits segment and the retirement solutions segment. The Asia segment contributes around 28% of earnings and is mainly composed of the Japan business with increasing contributions from India, China, and Bangladesh. The company also holds leading market positions in Mexico and Chile with the Latin America segment contributing around 6% of earnings. The EMEA and the MetLife segments contribute around 5% and 20% of earnings, respectively.

Contact
200 Park Avenue
New York, NY, 10166-0188
T +1 212 578-9500
Industry Insurance - Life
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 43,000

Related News MET